Position in FTRE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$146,403,790
+$70,115,761 QoQ
Shares Held
8,414,011
+3.9% QoQ
Ownership
8.85%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2
of 334 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Derivatives in FTRE
reported options exposure · as of Dec 31, 2024CallValue
$5,595,000
CallShares
300,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. FTRE ranks #19 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in FTRE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $146,403,790 | 8,414,011 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $76,288,029 | 8,098,517 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $142,702,298 | 8,272,597 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $67,179,853 | 7,978,605 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $39,023,529 | 7,899,500 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,637,219 | 481,751 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $6,994,234 | 375,026 | Shares | Defined | 2025-02-11 | |
| 2024-12-31 | $5,595,000 | 300,000 | Call | Defined | 2025-02-11 | |
| 2024-09-30 | $9,862,880 | 493,144 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,853,824 | 507,876 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $21,186,893 | 527,825 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,758,479 | 222,306 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $3,330,534 | 116,493 | Shares | Defined | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||